Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

PAXgene® Blood DNA Tube CE Enables Global PT Scheme

Published: Wednesday, April 09, 2014
Last Updated: Wednesday, April 09, 2014
Bookmark and Share
Global Proficiency Testing scheme for DNA extraction from whole blood enabled for the first time.

IBBL (Integrated BioBank of Luxembourg) has announced the results of its biorepository Proficiency Testing (PT) Programme, endorsed by ISBER (International Society for Biological and Environmental Repositories).

This year, for the first time, the biobank was able to offer a PT testing scheme for DNA extraction from whole blood, thanks to the PAXgene® Blood DNA Tube CE, from PreAnalytiX GmbH, a joint venture between leading medical technology company BD (Becton, Dickinson and Company) and QIAGEN, a global leader in molecular sample and assay technologies.

High quality biospecimens stored within biorepositories are becoming increasingly important to healthcare professionals and researchers in identifying and validating biomarkers for disease and drug therapy.

The optimal management of the collection, processing and storage of these biospecimens is vitally important to reduce pre-analytical error and ensure that samples are of high quality.

The aim of IBBL’s PT programme is to allow biorepositories to assess the accuracy of their quality control assays and biospecimens characterization and to compare their results with those obtained in other laboratories around the world.

Healthcare companies PreAnalytiX and BD, have teamed up with IBBL for one of its key PT testing schemes - ‘DNA Extraction Efficiency’- and supplied PAXgene® Blood DNA Tube CE, a CE marked, 2D barcoded 2.5 ml blood collection tube that stabilizes genomic DNA with validated time and temperature parameters, to help ensure stability of DNA during transportation.

For the PT scheme, whole blood was shipped in PAXgene® Blood DNA Tubes from Luxembourg to participants in other European countries, Asia, Australia and the USA, confirming the tube’s suitability for international transportation of whole blood.

“We would not have been able to offer this scheme without the PAXgene® DNA Tube,” comments Dr. Fay Betsou, IBBL’s Chief of Biospecimen Science and Coordinator of the PT programme. “The tube not only stabilizes DNA, but it is also compatible with all DNA extraction methods, including magnetic bead-based, silica membrane-based and salting out methods. This is a key factor in PT testing.”

Over 90 biorepositories participated in IBBL’s PT programme, of which 23 took part in the ‘DNA Extraction Efficiency’ scheme. All of the participants successfully extracted DNA and the results in terms of DNA yield and purity were coherent and satisfactory in all cases.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Poverty Marks a Gene, Predicting Depression
New study of high-risk teens reveals a biological pathway for depression.
World’s Largest Coral Gene Database
‘Genetic toolkit’ will help shed light on which species survive climate change.
Early Genetic Changes in Premalignant Colorectal Tissue Identified
Findings point to drivers of early cancer development, targets for cancer prevention therapies.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Modified Microalgae Converts Sunlight into Valuable Medicine
A special type of microalgae can soon produce valuable chemicals such as cancer treatment drugs and much more just by harnessing energy from the sun.
Breakthrough Approach to Breast Cancer Treatment
Scripps scientists have designed a drug candidate that decreases growth of breast cancer cells.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
A Guide to CRISPR Gene Activation
A comparison of synthetic gene-activating Cas9 proteins can help guide research and development of therapeutic approaches.
Gene That Lowers Heart Attack Risk Identified
Individuals with a rare twelve-letter deletion from a gene on chromosome 17 have significantly reduced non-HDL cholesterol levels and a 35% lower than average risk of heart disease.
Testing Non-Breast/Ovarian Cancer Genes
Researchers have found that expanding gene panel beyond breast/ovarian cancer genes in these patients does not add any clinical benefit. Instead, testing has produced more questions than answers.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!